| Autor: |
Hoskovec D; 1st Department of Surgery, General University Hospital, U nemocnice 2, 12000 Prague, Czech Republic.; 1st Medical Faculty, Charles University, Katerinska 32, 12000 Prague, Czech Republic., Krška Z; 1st Department of Surgery, General University Hospital, U nemocnice 2, 12000 Prague, Czech Republic.; 1st Medical Faculty, Charles University, Katerinska 32, 12000 Prague, Czech Republic., Škrha J; 1st Medical Faculty, Charles University, Katerinska 32, 12000 Prague, Czech Republic.; 3rd Department of Inner Medicine, General University Hospital, U nemocnice 2, 12000 Prague, Czech Republic., Klobušický P; 1st Medical Faculty, Charles University, Katerinska 32, 12000 Prague, Czech Republic., Dytrych P; 1st Department of Surgery, General University Hospital, U nemocnice 2, 12000 Prague, Czech Republic.; 1st Medical Faculty, Charles University, Katerinska 32, 12000 Prague, Czech Republic. |
| Abstrakt: |
Background and Objectives: Insulinoma is a rare tumor of the Langerhans islets of the pancreas. It produces insulin and causes severe hypoglycemia with neuroglycopenic symptoms. The incidence is low, at about 1-2 per 1 million inhabitants per year. The diagnosis is based on the presence of Whipple's triad and the result of a fasting test. Surgery is the treatment of choice. Objectives: A retrospective observational study of patients operated on for insulinoma in our hospital focused on the diagnosis, the type of surgery, and complications. Materials and Methods: We retrospectively reviewed patients operated on due to insulinoma. There were 116 surgeries between 2000 and 2022. There were 79 females and 37 males in this group. A fasting test and a CT examination were performed on all the patients. Results: The average duration of the fasting test was 18 h. Insulinoma was found in the body and tail of the pancreas in more than half of the patients. Enucleation was the most frequent type of surgery. Complications that were Clavien Dindo grade III or more occurred in 18% of the patients. The most frequent complications were abscesses and pancreatic fistula. Five patients had malignant insulinoma. Conclusions: Surgery is the treatment of choice in the case of insulinomas. The enucleation of the tumor is a sufficient treatment for benign insulinomas, which are not in contact with the main pancreatic duct. Due to the low incidence of the condition, the centralization of patients is recommended. |
